LI-RADS V2017 for Liver Nodules: How We Read and Report

Overview

Journal Cancer Imaging

Publisher Springer Nature

Specialties Oncology
Radiology

Date 2018 Apr 26

PMID 29690933

Citations 11

Authors

Wolfgang Schima

Jay Heiken

Affiliations

Soon will be listed here.

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) standardizes the interpretation and reporting of imaging examinations in patients at risk for hepatocellular carcinoma (HCC). For focal liver observations it assigns categories (LR-1 to 5, LR-M, LR-TIV), which reflect the relative probability of benignity or malignancy of the respective observation. The categories assigned are based on major and ancillary image features, which have been developed by the American College of Radiology (ACR) and validated in many studies. This review summarizes the relevant CT and MRI features and presents an image-guided approach for readers not familiar with LI-RADS on how to use the system. The widespread adoption of LI-RADS for reporting would help reduce inter-reader variability and improve communication among radiologists, hepatologists, hepatic surgeons and oncologists, thus leading to improved patient management.

Citing Articles

[Multiparametric magnetic resonance imaging for hepatocellular carcinoma, part 1 : Morphology and dynamic perfusion imaging in primary diagnostics and treatment monitoring].

Jahn M, Layer G Radiologie (Heidelb). 2024; 64(4):321-332.

PMID: 38502373 DOI: 10.1007/s00117-024-01285-1.

Prediction microvascular invasion of hepatocellular carcinoma based on tumour margin enhancing pattern in multiphase computed tomography images.

Nimitrungtawee N, Inmutto N, Amantakul A, Jantarangkoon A Pol J Radiol. 2023; 88:e238-e243.

PMID: 37346425 PMC: 10280366. DOI: 10.5114/pjr.2023.127578.

Hepatocellular carcinoma: State of the art diagnostic imaging.

Criss C, Nagar A, Makary M World J Radiol. 2023; 15(3):56-68.

PMID: 37035828 PMC: 10080581. DOI: 10.4329/wjr.v15.i3.56.

Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report.

Wu Y, Ou S, Liao X, Han C, Yang C, Qin W Pharmgenomics Pers Med. 2023; 16:111-120.

PMID: 36785780 PMC: 9921441. DOI: 10.2147/PGPM.S376596.

A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

De Muzio F, Grassi F, DellAversana F, Fusco R, Danti G, Flammia F Diagnostics (Basel). 2022; 12(7).

PMID: 35885561 PMC: 9319674. DOI: 10.3390/diagnostics12071655.

References

Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3):1020-2. PMC: 3084991. DOI: 10.1002/hep.24199. View

An C, Rakhmonova G, Choi J, Kim M . Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm. Clin Mol Hepatol. 2016; 22(2):296-307. PMC: 4946409. DOI: 10.3350/cmh.2016.0028. View

Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y . JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer. 2015; 3(3-4):458-68. PMC: 4531423. DOI: 10.1159/000343875. View

Potretzke T, Tan B, Doyle M, Brunt E, Heiken J, Fowler K . Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases. AJR Am J Roentgenol. 2016; 207(1):25-31. DOI: 10.2214/AJR.15.14997. View

Hope T, Fowler K, Sirlin C, Costa E, Yee J, Yeh B . Hepatobiliary agents and their role in LI-RADS. Abdom Imaging. 2014; 40(3):613-25. DOI: 10.1007/s00261-014-0227-5. View

Shah A, Tang A, Santillan C, Sirlin C . Cirrhotic liver: What's that nodule? The LI-RADS approach. J Magn Reson Imaging. 2015; 43(2):281-94. DOI: 10.1002/jmri.24937. View

Marin D, Roy Choudhury K, Gupta R, Ho L, Allen B, Schindera S . Clinical impact of an adaptive statistical iterative reconstruction algorithm for detection of hypervascular liver tumours using a low tube voltage, high tube current MDCT technique. Eur Radiol. 2013; 23(12):3325-35. DOI: 10.1007/s00330-013-2964-1. View

Schima W, Hammerstingl R, Catalano C, Marti-Bonmati L, Rummeny E, Montero F . Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. AJR Am J Roentgenol. 2006; 186(6):1571-9. DOI: 10.2214/AJR.05.1226. View

Tang A, Bashir M, Corwin M, Cruite I, Dietrich C, Do R . Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. Radiology. 2017; 286(1):29-48. PMC: 6677284. DOI: 10.1148/radiol.2017170554. View

10.

Jha R, Mitchell D, Weinreb J, Santillan C, Yeh B, Francois R . LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas. AJR Am J Roentgenol. 2014; 203(1):W48-69. DOI: 10.2214/AJR.13.12169. View

11.

Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T . Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology. 2008; 250(2):435-43. DOI: 10.1148/radiol.2501071702. View

12.

Sofue K, Sirlin C, Allen B, Nelson R, Berg C, Bashir M . How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma. J Magn Reson Imaging. 2015; 43(6):1337-45. DOI: 10.1002/jmri.25094. View

13.

Purysko A, Remer E, Coppa C, Filho H, Thupili C, Veniero J . LI-RADS: a case-based review of the new categorization of liver findings in patients with end-stage liver disease. Radiographics. 2012; 32(7):1977-95. DOI: 10.1148/rg.327125026. View

14.

Choi J, Cho H, Sun M, Kim H, Sirlin C . Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications. AJR Am J Roentgenol. 2013; 201(5):993-1001. DOI: 10.2214/AJR.12.10007. View

15.

Fraum T, Tsai R, Rohe E, Ludwig D, Salter A, Nalbantoglu I . Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014. Radiology. 2017; 286(1):158-172. DOI: 10.1148/radiol.2017170114. View

16.

Catalano O, Choy G, Zhu A, Hahn P, Sahani D . Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology. 2009; 254(1):154-62. DOI: 10.1148/radiol.09090304. View

17.

Kim M, Choi J, Lim J, Kim J, Kim J, Oh Y . Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. AJR Am J Roentgenol. 2006; 187(1):198-206. DOI: 10.2214/AJR.05.0257. View

18.

Choi J, Lee J, Sirlin C . CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014; 272(3):635-54. PMC: 4263631. DOI: 10.1148/radiol.14132361. View

19.

Kawata S, Murakami T, Kim T, Hori M, Federle M, Kumano S . Multidetector CT: diagnostic impact of slice thickness on detection of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol. 2002; 179(1):61-6. DOI: 10.2214/ajr.179.1.1790061. View

20.

Elsayes K, Hooker J, Agrons M, Kielar A, Tang A, Fowler K . 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics. 2017; 37(7):1994-2017. DOI: 10.1148/rg.2017170098. View